[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Moderator","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Jeff L. Summers<\/i><\/u><\/presenter>. U.S. Food and Drug Administration, Silver Spring White Oak, MD","CSlideId":"","ControlKey":"ae395956-ded4-4f70-af8a-8640e6a4152d","ControlNumber":"7899","DisclosureBlock":"&nbsp;<b>J.L. Summers:<\/b> None.","End":"4\/11\/2022 2:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"13734","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Jeff Summers, MD","PresenterKey":"1161323d-3b45-4d64-8c3a-e021cd4857c0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Moderator","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022  2:30PM","SessionId":"491","SessionOnDemand":"False","SessionTitle":"Successful Development of Cancer Therapies for Ultra-Rare Indications","ShowChatLink":"false","Start":"4\/11\/2022 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Moderator","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Jeff L. Summers<\/i><\/u><\/presenter>. U.S. Food and Drug Administration, Silver Spring White Oak, MD","CSlideId":"","ControlKey":"7441f520-0888-4daf-8ecf-2d07ccf52974","ControlNumber":"9144","DisclosureBlock":"","End":"4\/11\/2022 2:41:00 PM","HasWebcast":null,"Highlights":[],"Id":"20538","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Jeff Summers, MD","PresenterKey":"1161323d-3b45-4d64-8c3a-e021cd4857c0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Introduction","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022  2:30PM","SessionId":"491","SessionOnDemand":"False","SessionTitle":"Successful Development of Cancer Therapies for Ultra-Rare Indications","ShowChatLink":"false","Start":"4\/11\/2022 2:31:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Jeffrey A. Toretsky<\/i><\/u><\/presenter>. Georgetown Lombardi Comp. Cancer Center, Washington, DC","CSlideId":"","ControlKey":"18686d01-60fd-4baf-8092-565aa753bf43","ControlNumber":"8914","DisclosureBlock":"","End":"4\/11\/2022 2:51:00 PM","HasWebcast":null,"Highlights":[],"Id":"19099","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Jeffrey Toretsky, MD","PresenterKey":"665cdee7-8349-41b9-b563-83b54d83b60e","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Speaker","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022  2:30PM","SessionId":"491","SessionOnDemand":"False","SessionTitle":"Successful Development of Cancer Therapies for Ultra-Rare Indications","ShowChatLink":"false","Start":"4\/11\/2022 2:41:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Speaker","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Josh Sommer<\/i><\/u><\/presenter>. Chordoma Foundation, Durham, NC","CSlideId":"","ControlKey":"13d40047-ce8a-46d9-92d4-94f44c170d50","ControlNumber":"8911","DisclosureBlock":"&nbsp;<b>J. Sommer, <\/b> None.","End":"4\/11\/2022 3:01:00 PM","HasWebcast":null,"Highlights":[],"Id":"19096","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Josh Sommer, B.S.","PresenterKey":"75353cb2-96f0-422f-a1af-b6cd0ae51027","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Speaker","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022  2:30PM","SessionId":"491","SessionOnDemand":"False","SessionTitle":"Successful Development of Cancer Therapies for Ultra-Rare Indications","ShowChatLink":"false","Start":"4\/11\/2022 2:51:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Speaker","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Donald C. Lo<\/i><\/u><\/presenter>. National Institutes of Health, Bethesda, MD","CSlideId":"","ControlKey":"02c6727a-3aeb-4e76-b0e0-68652dd4fd31","ControlNumber":"8909","DisclosureBlock":"&nbsp;<b>D. C. Lo, <\/b> None.","End":"4\/11\/2022 3:11:00 PM","HasWebcast":null,"Highlights":[],"Id":"19094","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Donald Lo, PhD","PresenterKey":"e68d890a-664d-480c-b779-00cfdc153c95","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Speaker","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022  2:30PM","SessionId":"491","SessionOnDemand":"False","SessionTitle":"Successful Development of Cancer Therapies for Ultra-Rare Indications","ShowChatLink":"false","Start":"4\/11\/2022 3:01:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Speaker","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Deepa Narayanan<\/i><\/u><\/presenter>. National Institutes of Health, Bethesda, MD","CSlideId":"","ControlKey":"412abbab-3bcc-4671-9fd6-0bb6984e4b06","ControlNumber":"8913","DisclosureBlock":"","End":"4\/11\/2022 3:21:00 PM","HasWebcast":null,"Highlights":[],"Id":"19098","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Deepa Narayanan, MS, CCDM","PresenterKey":"0245d3ea-8bd0-4714-b2a7-3b6cdc11dd62","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Speaker","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022  2:30PM","SessionId":"491","SessionOnDemand":"False","SessionTitle":"Successful Development of Cancer Therapies for Ultra-Rare Indications","ShowChatLink":"false","Start":"4\/11\/2022 3:11:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Speaker","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Michael Stebbins<\/i><\/u><\/presenter>. Science Advisors, LLC, Alexandria, VA","CSlideId":"","ControlKey":"fda73d54-0691-49e5-815d-6690fdd562b7","ControlNumber":"9775","DisclosureBlock":"","End":"4\/11\/2022 3:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"21317","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Michael Stebbins, PhD","PresenterKey":"9c12b8f8-35cd-48bc-baa3-84bbf860dac0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Speaker","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022  2:30PM","SessionId":"491","SessionOnDemand":"False","SessionTitle":"Successful Development of Cancer Therapies for Ultra-Rare Indications","ShowChatLink":"false","Start":"4\/11\/2022 3:21:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Speaker","Topics":null,"cSlideId":""},{"Abstract":"Panel Discussion with Q&#38;A","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"e10cc04d-c5f4-49f0-81fd-28e80066dce3","ControlNumber":"9145","DisclosureBlock":"","End":"4\/11\/2022 4:21:00 PM","HasWebcast":null,"Highlights":[],"Id":"20539","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panel Discussion with Q&#38;A","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022  2:30PM","SessionId":"491","SessionOnDemand":"False","SessionTitle":"Successful Development of Cancer Therapies for Ultra-Rare Indications","ShowChatLink":"false","Start":"4\/11\/2022 3:41:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panel Discussion with Q&#38;A","Topics":null,"cSlideId":""}]